Research Article
Arterial Stiffness in Breast Cancer Patients Treated with Anthracycline and Trastuzumab-Based Regimens
Table 5
Mobilograph measurement indices.
| | Control () | Patient () | |
| pSBP (mmHg) | 116.7 ± 16.1 | 123.3 ± 11.9 | 0.050 | pDBP (mmHg) | 73.4 ± 14 | 83 ± 10.6 | 0.001 | pMAP (mmHg) | 92.3 ± 13.2 | 102.2 ± 12 | <0.001 | bPP (mmHg) | 42.1 ± 13.9 | 43.5 ± 10.7 | 0.66 | cSBP (mmHg) | 108.6 ± 16.3 | 114.9 ± 15 | 0.090 | cDBP (mmHg) | 74.8 ± 14 | 84.5 ± 10.6 | 0.001 | aPP (mmHg) | 33.8 ± 9.1 | 30.4 ± 10.1 | 0.144 | CO (L/min) | 4.1 ± 0.5 | 4.4 ± 0.7 | 0.077 | Peripheral resistance | 1.2 ± 0.1 | 1.3 ± 0.2 | 0.160 | CI (L/m2 × 1/m2) | 2.2 (1.7 to 3) | 2.4 (2 to 5.6) | 0.074 | Augmentation pressure | 7.4 ± 6 | 7.3 ± 4.1 | 0.868 | Augmentation index | 23.5 (−19 to 42) | 29.5 (1 to 53) | 0.010 | CO | 4 (3.2 to 5.5) | 4.4 (3.3 to 8.3) | 0.050 | Pulse wave velocity | 5.8 ± 1.4 | 7.3 ± 1.2 | <0.001 |
|
|
pSBP: peripheral systolic blood pressure; pDBP: peripheral diastolic blood pressure; pMAP: periferic mean arterial pressure; bPP: brachial pulse pressure; cDBP: central diastolic blood pressure; cSBP: central systolic blood pressure; aPP: aortic pulse pressure; CO: cardiac output; CI: cardiac index.
|